Evidence map›Paper›PMID 26817845›Full record

ArticleThe Journal of biological chemistry2016

Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.

Cyril X George, Gokul Ramaswami, Jin Billy Li, Charles E Samuel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. RNA editing and immune control: from mechanism to therapy.Current opinion in genetics & development · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Cyril X GeorgeFrom the Department of Molecular, Cellular and Developmental Biology and.
Gokul Ramaswamithe Department of Genetics, Stanford University, Stanford, California 94305.
Jin Billy Lithe Department of Genetics, Stanford University, Stanford, California 94305.ORCID http://orcid.org/0000-0003-0713-1399
Charles E SamuelFrom the Department of Molecular, Cellular and Developmental Biology and the Biomolecular Sciences and Engineering Program, University of California, Santa Barbara, California 93106 and samuel@lifesci.ucsb.edu.
Institut thématique Génétique, génomique et bioinformatique · FRStanford University · US

Funding

INTERFERON ACTION AND PROTEIN PHOSPHORYLATIONR01AI020611 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SAMUEL, CHARLES E · 1985 to 2014
$3.4M
Profiling and Dissecting the Dynamic Regulation of RNA EditingR01GM102484 · NIGMS · STANFORD UNIVERSITY · PI LI, JIN BILLY · 2013 to 2021
$3.1M
MECHANISM OF INTERFERON ACTIONR01AI012520 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SAMUEL, CHARLES E · 1985 to 2009
$3.1M
MECHANISM OF INTERFERON ACTIONR37AI012520 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SAMUEL, CHARLES E. · 1989 to 1998
–
NIAID NIH HHS AI-12520NIAID NIH HHS AI-20611NIAID NIH HHS R01 AI012520NIAID NIH HHS R01 AI020611NIAID NIH HHS R37 AI012520NIGMS NIH HHS GM-202484NIGMS NIH HHS R01 GM102484
6 · The paper itself

Abstract

Adenosine deaminases acting on double-stranded RNA (ADARs) catalyze the deamination of adenosine (A) to produce inosine (I) in double-stranded (ds) RNA structures, a process known as A-to-I RNA editing. dsRNA is an important trigger of innate immune responses, including interferon (IFN) production and action. We examined the role of A-to-I RNA editing by two ADARs, ADAR1 and ADAR2, in the sensing of self-RNA in the absence of pathogen infection, leading to activation of IFN-induced, RNA-mediated responses in mouse embryo fibroblasts. IFN treatment of Adar1(-/-) cells lacking both the p110 constitutive and p150 IFN-inducible ADAR1 proteins induced formation of stress granules, whereas neither wild-type (WT) nor Adar2(-/-) cells displayed a comparable stress granule response following IFN treatment. Phosphorylation of protein synthesis initiation factor eIF2α at serine 51 was increased in IFN-treated Adar1(-/-) cells but not in either WT or Adar2(-/-) cells following IFN treatment. Analysis by deep sequencing of mouse exonic loci containing A-to-I-editing sites revealed that the majority of editing in mouse embryo fibroblasts was carried out by ADAR1. IFN treatment increased editing in both WT and Adar2(-/-) cells but not in either Adar1(-/-) or Adar1(-/-) (p150) cells or Stat1(-/-) or Stat2(-/-) cells. Hyper-edited sites found in predicted duplex structures showed strand bias of editing for some RNAs. These results implicate ADAR1 p150 as the major A-to-I editor in mouse embryo fibroblasts, acting as a feedback suppressor of innate immune responses otherwise triggered by self-RNAs possessing regions of double-stranded character.

Indexed as

Immunity, InnateRNA EditingAdenosine DeaminaseAnimalsCells, CulturedCytoplasmic GranulesDeaminationEukaryotic Initiation Factor-2FibroblastsImmune ToleranceInterferon-alphaMice, KnockoutPhosphorylationProtein Processing, Post-TranslationalRNA-Binding ProteinsRNA, Double-StrandedADAR1 protein, mouseADAR2 protein, mouseAdenosine DeaminaseEukaryotic Initiation Factor-2Interferon-alphaRNA-Binding ProteinsRNA, Double-Strandedadenosine deaminase acting on RNA (ADAR)innate immunityinterferonprotein kinase RNA-activated (PKR)RNA editingstress granule

Identifiers

PMID26817845
PMCPMC4813567
OpenAlexW2291649422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.